We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+22.3%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$455M
AUM Growth
+$90.7M
Cap. Flow
+$33.6M
Cap. Flow %
7.38%
Top 10 Hldgs %
56.91%
Holding
55
New
3
Increased
34
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$15.3M
2
SHPG
Shire pic
SHPG
+$13.8M
3
NEO icon
NeoGenomics
NEO
+$7.39M
4
NVTR
Nuvectra Corporation Common Stock
NVTR
+$4.2M
5
HBIO icon
Harvard Bioscience
HBIO
+$3.6M

Top Sells

Rank Stock Value
1
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$16.4M
2
NKTR icon
Nektar Therapeutics
NKTR
+$4.44M
3
BLUE
bluebird bio
BLUE
+$2.44M
4
QDEL icon
QuidelOrtho
QDEL
+$2.04M
5
CDXS icon
Codexis
CDXS
+$1.63M

Sector Composition

Rank Sector Weight
1 Healthcare 84.88%
2 Communication Services 4.24%
3 Energy 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
51
Sanofi
SNY
$103B
$269K 0.06%
6,720
– –
MRK icon
52
Merck
MRK
$322B
$234K 0.05%
4,500
– –
MGNX icon
53
MacroGenics
MGNX
$235M
– –
-73,558
Closed -$1.4M
XBI icon
54
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-9,499
Closed -$806K
ENTL
55
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-670,904
Closed -$16.4M
1 2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, First Light Asset Management held 55 positions worth $455M, up 25% from $365M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

First Light Asset Management deployed $33.6M of net new capital in Q1 2018, opening 3 new positions and adding to 34 existing holdings. Its largest new stake was Tandem Diabetes Care: 4,734,238 shares worth $23.5M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 84% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Nektar Therapeutics, an estimated $4.44M trimmed.

  • First Light Asset Management's largest Q1 2018 buy was Tandem Diabetes Care: 4,734,238 shares worth $23.5M.
  • First Light Asset Management added most to Shire pic in Q1 2018, an estimated $13.8M increase.
  • First Light Asset Management's biggest Q1 2018 reduction was Nektar Therapeutics, cutting an estimated $4.44M.
  • First Light Asset Management fully exited Entellus Medical, Inc. Common Stock in Q1 2018, selling an estimated $16.4M.
  • First Light Asset Management's ten largest holdings make up 57% of its $455M portfolio in Q1 2018.
  • First Light Asset Management opened 3 new positions and closed 3 in Q1 2018.
  • First Light Asset Management's portfolio value rose 25% quarter-over-quarter to $455M.

Based on First Light Asset Management's 13F filing for Q1 2018, filed 15 May 2018.